X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Emami Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs EMAMI LTD - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES EMAMI LTD AMAR REMEDIES/
EMAMI LTD
 
P/E (TTM) x -0.5 34.8 - View Chart
P/BV x 0.1 5.8 1.0% View Chart
Dividend Yield % 0.0 1.6 -  

Financials

 AMAR REMEDIES   EMAMI LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
EMAMI LTD
Mar-18
AMAR REMEDIES/
EMAMI LTD
5-Yr Chart
Click to enlarge
High Rs1641,428 11.5%   
Low Rs861,000 8.6%   
Sales per share (Unadj.) Rs261.6111.5 234.7%  
Earnings per share (Unadj.) Rs17.413.5 128.4%  
Cash flow per share (Unadj.) Rs22.327.2 81.8%  
Dividends per share (Unadj.) Rs08.43 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs100.788.7 113.5%  
Shares outstanding (eoy) m26.16226.97 11.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.510.9 4.4%   
Avg P/E ratio x7.289.6 8.0%  
P/CF ratio (eoy) x5.644.6 12.6%  
Price / Book Value ratio x1.213.7 9.1%  
Dividend payout %062.2 0.0%   
Avg Mkt Cap Rs m3,270275,542 1.2%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m1632,547 6.4%   
Avg. sales/employee Rs ThNM7,687.0-  
Avg. wages/employee Rs ThNM773.5-  
Avg. net profit/employee Rs ThNM934.1-  
INCOME DATA
Net Sales Rs m6,84425,305 27.0%  
Other income Rs m21195 10.8%   
Total revenues Rs m6,86525,500 26.9%   
Gross profit Rs m1,1317,194 15.7%  
Depreciation Rs m1283,109 4.1%   
Interest Rs m398343 116.0%   
Profit before tax Rs m6263,938 15.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121863 14.0%   
Profit after tax Rs m4553,075 14.8%  
Gross profit margin %16.528.4 58.1%  
Effective tax rate %19.321.9 88.2%   
Net profit margin %6.612.2 54.7%  
BALANCE SHEET DATA
Current assets Rs m4,9047,008 70.0%   
Current liabilities Rs m3,5817,139 50.2%   
Net working cap to sales %19.3-0.5 -3,711.5%  
Current ratio x1.41.0 139.5%  
Inventory Days Days12428 444.2%  
Debtors Days Days10022 445.4%  
Net fixed assets Rs m1,6898,231 20.5%   
Share capital Rs m262227 115.4%   
"Free" reserves Rs m2,35819,909 11.8%   
Net worth Rs m2,63520,136 13.1%   
Long term debt Rs m5070-   
Total assets Rs m6,86228,007 24.5%  
Interest coverage x2.612.5 20.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.00.9 110.4%   
Return on assets %12.412.2 101.9%  
Return on equity %17.315.3 113.1%  
Return on capital %31.021.3 145.8%  
Exports to sales %4.03.9 102.5%   
Imports to sales %00-   
Exports (fob) Rs m273985 27.7%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2731,063 25.7%   
Fx outflow Rs m2400 0.5%   
Net fx Rs m271663 40.9%   
CASH FLOW
From Operations Rs m-3135,878 -5.3%  
From Investments Rs m-489-2,791 17.5%  
From Financial Activity Rs m769-3,237 -23.7%  
Net Cashflow Rs m-33-122 26.6%  

Share Holding

Indian Promoters % 25.5 70.6 36.1%  
Foreign collaborators % 0.0 2.2 -  
Indian inst/Mut Fund % 9.2 1.3 707.7%  
FIIs % 0.0 16.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 9.2 709.8%  
Shareholders   13,061 25,076 52.1%  
Pledged promoter(s) holding % 99.7 19.5 511.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   HIND. UNILEVER  P&G HYGIENE  GODREJ CONSUMER  BATA INDIA  COLGATE  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Related Views on News

EMAMI LTD Announces Quarterly Results (1QFY19); Net Profit Up 2491.3% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, EMAMI LTD has posted a net profit of Rs 270 m (up 2491.3% YoY). Sales on the other hand came in at Rs 6 bn (up 13.5% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

EMAMI LTD Announces Quarterly Results (4QFY18); Net Profit Down 27.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, EMAMI LTD has posted a net profit of Rs 609 m (down 27.0% YoY). Sales on the other hand came in at Rs 6 bn (up 6.8% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS